Xenon Pharmaceuticals Inc... (XENE)
NASDAQ: XENE
· Real-Time Price · USD
38.23
0.27 (0.71%)
At close: Aug 15, 2025, 3:59 PM
38.23
0.00%
After-hours: Aug 15, 2025, 04:42 PM EDT
Xenon Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 7.5M | n/a | 5.38M | 5.38M | 5.38M | 5.38M | 8.77K | 140.77K | 676.77K | 9.44M | 13.17M | 21.16M | 22.84M | 18.44M | 19.85M | 18.28M | 29.45M |
Cost of Revenue | 659K | 1.26M | 2.11M | 3.84M | 3.79M | 3.54M | 3.21M | 30.9M | 52.45M | 71.45M | 92.82M | 82.28M | 78.52M | 75.46M | 68.54M | 62.7M | 55.04M |
Gross Profit | -659K | -1.26M | 3.27M | 1.54M | 1.59M | 1.84M | -3.2M | -30.76M | -51.77M | -62.01M | -79.65M | -61.12M | -55.67M | -57.03M | -48.69M | -44.42M | -25.59M |
Operating Income | -293M | -279.3M | -255.52M | -237.52M | -224.04M | -214.05M | -203.69M | -186.13M | -160.82M | -129.14M | -110.65M | -88.12M | -80.3M | -78.99M | -67.08M | -61.18M | -39.33M |
Interest Income | 38.67M | 41.94M | 41.21M | 37.87M | 33.55M | 27.62M | 23.39M | 19.48M | 13.77M | 8.71M | 4.51M | 1.52M | 779K | 557K | 383K | 473K | 1.31M |
Pretax Income | -255.52M | -238.42M | -213.83M | -199.34M | -188.77M | -182.69M | -173.99M | -163.11M | -146.63M | -125.25M | -114.08M | -91.99M | -83.12M | -78.89M | -66.14M | -59.55M | -37.44M |
Net Income | -251.45M | -234.33M | -213.39M | -199.06M | -188.6M | -182.39M | -175.04M | -163.73M | -147.43M | -125.37M | -113.54M | -91.84M | -82.79M | -78.88M | -65.64M | -59.05M | -37.12M |
Selling & General & Admin | 73.15M | 68.31M | 62.07M | 58.17M | 50.35M | 45.69M | 42.42M | 38.45M | 35.57M | 32.81M | 31M | 27M | 24.63M | 21.97M | 18.39M | 16.76M | 13.73M |
Research & Development | 227.34M | 210.39M | 192M | 177.91M | 172.25M | 167.51M | 161.27M | 147.82M | 125.92M | 105.77M | 92.82M | 82.28M | 78.52M | 75.46M | 68.54M | 62.7M | 55.04M |
Other Expenses | n/a | n/a | n/a | 7.07M | 15.01M | 15.01M | 22.08M | 15.02M | 7.08M | 7.08M | n/a | n/a | n/a | n/a | n/a | n/a | 432K |
Operating Expenses | 300.5M | 278.7M | 254.07M | 236.07M | 222.59M | 213.2M | 203.69M | 186.27M | 161.49M | 138.58M | 123.82M | 109.28M | 103.15M | 97.43M | 86.93M | 79.46M | 68.77M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19K | 19K | 19K | 19K | n/a | 154K |
Selling & Marketing Expenses | n/a | -599K | -1.45M | -1.45M | -1.45M | -851K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 222.11M | 281.15M | 255.52M | 237.52M | 224.04M | 214.05M | 203.69M | 186.27M | 161.49M | 138.58M | 123.82M | 109.28M | 103.15M | 97.43M | 86.93M | 79.46M | 68.77M |
Income Tax Expense | -4.93M | -4.09M | -446K | -283K | -170K | -292K | 1.05M | 622K | 802K | 118K | -537K | -155K | -332K | -6K | -504K | -502K | -324K |
Shares Outstanding (Basic) | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 62.54M | 56.19M | 53.06M | 41.19M | 41.19M | 42.09M | 36.82M |
Shares Outstanding (Diluted) | 78.69M | 78.39M | 77.93M | 77.67M | 77.59M | 69.97M | 66M | 65.86M | 65.72M | 65.66M | 65.47M | 56.19M | 54.85M | 41.19M | 42.27M | 42.09M | 36.82M |
EPS (Basic) | -3.23 | -3.02 | -2.82 | -2.74 | -2.71 | -2.72 | -2.65 | -2.51 | -2.34 | -2.08 | -2.13 | -1.91 | -1.89 | -1.95 | -1.68 | -1.56 | -1.03 |
EPS (Diluted) | -3.23 | -3.02 | -2.82 | -2.74 | -2.71 | -2.72 | -2.65 | -2.49 | -2.32 | -2.05 | -2.1 | -1.9 | -1.88 | -1.95 | -1.66 | -1.54 | -1.01 |
EBITDA | -291.03M | -276.74M | -252.74M | -233.68M | -220.26M | -210.51M | -198.72M | -182.53M | -157.45M | -125.75M | -109.51M | -87.13M | -79.46M | -78.33M | -65.65M | -59.15M | -36.78M |
EBIT | -212.31M | -271.35M | -255.52M | -237.52M | -224.04M | -214.05M | -199.8M | -182.25M | -156.94M | -125.25M | -110.89M | -88.36M | -80.55M | -79.23M | -66.49M | -59.95M | -37.51M |
Depreciation & Amortization | 1.96M | 2.56M | 2.78M | 3.84M | 3.79M | 3.54M | 3.21M | 1.83M | 1.6M | 1.62M | 1.38M | 1.23M | 1.09M | 906K | 838K | 800K | 736K |